Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Drug Usage
Drug Usage
15 registered clinical trials studyying Drug Usage.
Status
Trial
Sponsor
Phase
Completed
Cooperation for Better Treatment of Polypharmacy in the Community
NCT06020391
Oslo University Hospital
N/A
Withdrawn
A Community-University Approach to Preventing HIV
NCT03938077
University of Michigan
N/A
Completed
Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention
NCT03368456
University of Michigan
N/A
Completed
Remifentanil for Preventing Propofol Injection Pain in Elderly Patients
NCT03330782
Ajou University School of Medicine
Phase 4
Completed
EC95 of Remifentanil for Preventing Cough
NCT02973724
Ajou University School of Medicine
N/A
Completed
Gabapentin as Adjunctive Treatment for Postoperative Pain Control
NCT02490345
Indiana University
Phase 1
Completed
Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Stu
NCT02379455
Oslo University Hospital
N/A
Completed
Remifentanil for Smooth Emergence in Elderly Patients
NCT02334046
Ajou University School of Medicine
Phase 4
Completed
Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)
NCT01931683
Ajou University School of Medicine
Phase 4
Completed
Dexmedetomidine for Laryngeal Mask Airway Insertion
NCT01852539
Ajou University School of Medicine
Phase 4
Completed
Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Stu
NCT01963130
Bezmialem Vakif University
—
Unknown
Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion
NCT01496105
Ain Shams University
Phase 4
Completed
Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine
NCT01489683
Ajou University School of Medicine
N/A
Completed
F.Y.I.: Flint Youth Injury Study
NCT01152970
University of Michigan
—
Completed
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
NCT00876941
Boston Medical Center
Phase 3